Topics - Manufacturing
Refine By
Content Type
FeaturesBreaking News
Columns
Editorial
Online Exclusives
Industry News
Industry Events
Buyers Guide Companies
Business Corner
Expert's Opinion
White Papers / Tech Papers
Classifieds
Services
Product Releases
Case Studies
Top Companies Report
Jobs
Videos
Collaborations & Alliances
Promotions & Movies
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
Advanced Degrees
Financial Analysis
I Mak
Lowe Down
Managing Your Careeer
Pharma Beat
Preclinical Outsourcing
Salary Survey
Outsourcing Survey
Contracting & Outsourcing
Literature / Brochures
CRO News
FDA Watch
India Report
Executive Perspective
Ask The Board
Glossary
Posters
News Releases
Provider Survey
Conference Sessions
Ask The Experts
By Gil Roth
Published April 19, 2012
Billion-dollar site to support plasma-based treatments Read More »
Published April 13, 2012
Special Economic Zone includes global manufacturing facilities Read More »
Published April 12, 2012
Lonza to produce commercial material at its facility in the Czech Republic Read More »
By Bernd Schummelfeder and Cristin Grove
Published April 4, 2012
Requirements for outsourcing high containment development activities Read More »
Published April 4, 2012
More opportunities, but greater regulatory scrutiny Read More »
Published March 29, 2012
Expands market reach to Europe Read More »
Published March 27, 2012
Will serve as the primary commercial manufacturer for Korlym Read More »
Published March 27, 2012
commended for commitment to aseptic processing and filling capabilities Read More »
Published March 23, 2012
Will develop undisclosed Rx product for U.S. with Hong Kong-based pharma Read More »
Published March 21, 2012
QS Pharma will manufacture OSTORA tablets for product launch Read More »
Published March 21, 2012
Will offer full bioprocess development services Read More »
Published March 14, 2012
Will complete full commercial manufacture of DuoCort’s Plenadren Read More »
Published March 13, 2012
Will provide commercial manufacture of talactoferrin
Read More »
Published March 9, 2012
Invests $22 million in development and manufacturing capabilities Read More »
Published March 8, 2012
Will provide manufacturing, registration, and validation services Read More »
